| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Transforming the Blood Collection Tube market For many years, the industry has recognized the need for a tube that rapidly produced high quality serum from the majority of blood samples. Q-Sera’s technology has been developed to create a new standard biochemistry tube to meet these needs and uses pro-coagulant proteins called prothrombin activators, the use of which is covered by global patent protection. These proteins are found in the venom of some snakes (including the Australian Taipan) that have a potent ability to coagulate the blood and are now manufactured ‘recombinantly’ using industry standard protein production technologies. |
| Category: | Health & biotech |
| URL: | https://www.q-sera.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | Victoria, 3000 |
| State: | Victoria |
| Overseas Operations: | No |
| X: | |
| Facebook: | |
| Linkedin: | |
| Founders: |
No items found
|
| Awards won: | |

